EMILY KUSGEN: Open Payments
NPI 1154078434 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 11 payments from 5 companies in 2025. Trend: 2023 $175 · 2024 $314 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| Novo Nordisk Inc | 2 | $50 |
| ABIOMED | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| GENZYME CORPORATION | 1 | $20 |
Products named: LEQVIO, Wegovy, ELIQUIS, FABRAZYME.
Industry payments across MO — which companies pay providers there.
